Rodrigues-Garv Regina MD is categorized under Internal Medicine Doctors in Rochester, NY .
Rodrigues-Garv Regina MD was established in 0, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Regina Rodrigues-Garv at the company’s single location by writing to 222 Alexander St, Rochester, New York NY 14607 or by phoning (585) 922-8350. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Rodrigues-Garv Regina MD |
| Contact Person: | Regina Rodrigues-Garv |
| Address: | 222 Alexander St, Rochester, New York 14607 |
| Phone Number: | (585) 922-8350 |
| Website Address: | rochestergeneral.org |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Rodrigues-Garv Regina MD was started in 0 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Regina Rodrigues-Garv for inquiries that concern Rodrigues-Garv Regina MD by calling the company number (585) 922-8350, as your correspondence is most welcome. Additionally, the physical location of the single location of Rodrigues-Garv Regina MD can be found at the coordinates 43.149889,-77.597075 as well as the street address 222 Alexander St in Rochester, New York 14607.
For its online presence, you may visit Rodrigues-Garv Regina MD’s website at rochestergeneral.org and engage with its social media outlets through on Twitter and on Facebook.